Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
Biogen inks outcomes-based contract for MS meds
BioPharma Dive
Thu, 12/7/17 - 09:05 am
Biogen
MS
multiple sclerosis
Prime Therapeutics
PBMs
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development
Alkermes shares rise 6% on Biogen multiple sclerosis drug partnership
Marketwatch
Mon, 11/27/17 - 09:10 am
Alkermes
Biogen
MS
multiple sclerosis
ALKS 8700
U.S. biotechs can’t shake October blues as investors await next moves
Globe and Mail, Canada
Sun, 11/19/17 - 09:53 am
biotech
investors
Biogen
Gilead Sciences
Celgene
Forget BMS. Pfizer should chase a Biogen buy, analyst suggests
Fierce Pharma
Mon, 11/13/17 - 08:53 pm
Pfizer
Bristol-Myers Squibb
Biogen
M&A
NEJM publishes Phase III results for Biogen/Ionis’ Spinraza
GoinPharma
Mon, 11/6/17 - 08:56 am
Biogen
Ionis Pharmaceuticals
Spinraza
clinical trials
spinal muscular atrophy
SMA
US Spinraza sales cause concern among Biogen investors
Biopharma Dive
Wed, 10/25/17 - 09:40 am
Biogen
Spinraza
spinal muscular atrophy
investors
Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up
Yahoo/Zacks.com
Tue, 10/24/17 - 05:35 pm
Biogen
earnings
Eisai shows confidence in Biogen's Alzheimer's drug
Biopharma Dive
Mon, 10/23/17 - 09:49 pm
Eisai
Biogen
Alzheimer's disease
aducanumab
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Yahoo/Zacks.com
Mon, 10/23/17 - 09:59 am
earnings
Eli Lilly
Biogen
Novartis
3 Drug Stocks Hitting 52-Week Highs
Motley Fool
Tue, 10/17/17 - 09:42 am
Biogen
Halozyme Therapeutics
Ionis Pharmaceuticals
Corrected: What Q3 earnings will look like for 5 pharma giants
Biopharma Dive
Sat, 10/14/17 - 11:33 am
earnings
JNJ
Roche
Biogen
Eli Lilly
Novartis
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial
Xconomy
Mon, 09/18/17 - 09:43 am
Rodin Therapeutics
Biogen
Alzheimer's disease
clinical trials
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
AbbVie
Humira
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Biogen
aducanumab
Biotech, pharma chime in over Trump’s move to halt immigration program
Drug Delivery Business News
Wed, 09/6/17 - 10:33 am
biotech
pharma industry
immigration
Decibel Therapeutics
Ovid Therapeutics
Biogen
DACA
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Biogen
Samsung Bioepis
Europe
Humira
AbbVie
Imraldi
biosimilars
Bioverativ taps patient social network for input on hemophilia trial design
Fierce Pharma
Thu, 08/24/17 - 10:41 pm
Bioverativ
social media
clinical trials
patients
hemophilia A
Biogen
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
Biogen gains over 1 billion in capitalization thanks to Alzheimer’s pipeline
GoInPharma
Thu, 08/17/17 - 11:47 pm
Biogen
Alzheimer's disease
aducanumab
Pages
« first
‹ previous
…
33
34
35
36
37
38
39
40
41
…
next ›
last »